Journal Home
Search for

Volume 142, Issue 3, Pages 322-326 (March 2010)


View previous. 9 of 43 View next.

Maxillary removal and reinsertion: A favorable approach for extensive anterior cranial base tumors

This article was presented at the Combined Otolaryngological Spring Meetings, Phoenix, AZ, May 30, 2009.

Enver Ozer, MDCorresponding Author Informationemail address, Sumit Bapna, MD, Amit Agrawal, MD, David E. Schuller, MD

Received 25 August 2009; received in revised form 18 September 2009; accepted 17 November 2009. published online 22 January 2010.

Abstract 

Objective

To analyze the long-term results and the complications related to an expanded series of maxillary removal and reinsertion (MRRI) with 18-year surgical experience.

Study Design

Case series with chart review of the MRRI patients in the last 18 years.

Setting

The Ohio State University Comprehensive Cancer Center, James Cancer Hospital and Solove Research Institute.

Subjects and Methods

Seventy-eight patients who underwent MRRI from February 1990 through February 2007. The median age was 51 years (range 11-77 yrs). Sixty-two (80%) patients had malignant lesions.

Results

MRRI has been successfully completed in all 78 patients, with no intraoperative mortality. The most commonly encountered malignant neoplasm was squamous cell cancer (40.3%), followed by esthesioneuroblastoma (24.1%), adenoid cystic cancer (8%), and other neoplasms (27.4%). The most commonly encountered postoperative complication was diplopia, which has persisted in five (6.4%) patients in the short-term and in three (4%) patients in the long-term follow-up. Nasal asymmetry was the most common long-term complication (17.9%), followed by plate-associated problems (10.2%) and midface asymmetry (10.2%). Overall five-year survival for the patients with squamous cell carcinoma was 62 percent.

Conclusion

MRRI is a favorable surgical technique for the treatment of anterior cranial base (ACB) tumors in adults and even in children. It improves operative morbidity by preserving both function and form of the maxillary region and gives excellent exposure to ACB.

Department of Otolaryngology–Head and Neck Surgery, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Comprehensive Cancer Center, the Ohio State University, Columbus, OH

Corresponding Author InformationCorresponding author: Enver Ozer, MD, Address: 456 W 10th Ave, Ste 4A, Columbus, OH 43210

 No sponsorships or competing interests have been disclosed for this article.

PII: S0194-5998(09)01776-8

doi:10.1016/j.otohns.2009.11.027


View previous. 9 of 43 View next.